...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Broker Meeting 23 Feb

"58% Chance that this Phase 3 BETonMACE will be successful" and "64% probability of apabetalone sales for indications in the BETonMACE trial" arent' exactly the same thing. Split the difference and call it 61%. Either way, it's all a guessing game in my opinion until Q3/Q4 when we get past the futility analysis.

BearDownAZ

Share
New Message
Please login to post a reply